Issue 44 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Caligiuri named president of City of Hope National Medical Center

Caligiuri: It was time for me to hit the refresh button on my career

Sharpless lists initial priorities for NCI: Big Data, cell therapy, and more trials at the NIH Clinical Center

FDA approves Foundation Medicine's genomic profiling test for all solid tumors; CMS proposes coverage

In Brief

FDA's Pazdur named to Bloomberg 50 list

National Academies report calls for government negotiation of drug prices

Antonio Wolff named chair of ECOG-ACRIN Breast Cancer Committee

Louis Weiner to lead MedStar Georgetown Cancer Institute

LLS awards $5 million grant to team led by Sylvester's Stephen Nimer

Ronda Henry-Tillman named to Kohn Chair in breast surgical oncology UAMS

NCCN, in collaboration with Pfizer, awards nine grants for quality improvement in breast cancer

Ronald Maier elected president of American College of Surgeons

Leigh Neumayer elected chair of the ACS board of regents

Drugs & Targets

FDA approves Ogivri, first biosimilar for treating breast and stomach cancers

Tesaro receives European approval of Zejula for recurrent ovarian cancer

G1 Therapeutics and AstraZeneca enter clinical trials collaboration in NSCLC

ITUS Corp. Moffitt enter into CRADA to develop CAR-T technology

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login